Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Oncotargets and Therapy|October 24, 2018
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinomaZhenfeng Zhu, Litao Xu, Liping Zhuang, et al.
Oncotargets and Therapy|March 14, 2019
High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cellsZhouyu Ning, Zhenfeng Zhu, Haiyong Wang, et al.
Molecular Oncology|November 27, 2012
The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasLPeng Wang, Liping Zhuang, Juan Zhang, et al.
Cancer|May 7, 2016
A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapyQi Qi, Liping Zhuang, Yehua Shen, et al.
Integrative Cancer Therapies|November 22, 2015
Jian Pi Li Qi Decoction Alleviated Postembolization Syndrome Following Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Randomized, Double-Blind, Placebo-Controlled TrialLitao Xu, Shiying Wang, Liping Zhuang, et al.
The American Journal of Chinese Medicine|January 19, 2023
Bufalin Inhibits Tumorigenesis and SREBP-1-Mediated Lipogenesis in Hepatocellular Carcinoma via Modulating the ATP1A1/CA2 AxisChang-Jing Huang, Chen-Yue Zhang, Ying-Ke Zhao, et al.
Gastroenterology|August 7, 2013
MicroRNA 23b regulates autophagy associated with radioresistance of pancreatic cancer cellsPeng Wang, Juan Zhang, Li Zhang, et al.
Scientific Reports|June 9, 2016
Hepatocellular carcinoma cell lines retain the genomic and transcriptomic landscapes of primary human cancersZhixin Qiu, Keke Zou, Liping Zhuang, et al.
Microsystems & Nanoengineering|October 29, 2024
MRI and CT compatible asymmetric bilayer hydrogel electrodes for EEG-based brain activity monitoringGuoqiang Ren, Mingxuan Zhang, Liping Zhuang, et al.
Canadian Journal of Gastroenterology & Hepatology|July 20, 2022
Serum Glial Cell Line-Derived Neurotrophic Factor (sGDNF) Is a Novel Biomarker in Predicting Cirrhosis in Patients with Chronic Hepatitis BGuangyue Yang, Liping Zhuang, Tiantian Sun, et al.
Pageof 6